NAMS Earnings & Financial Statements
NewAmsterdam Pharma Company N.V.
$19.71
-$1.87(-8.67%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
2.31M
52W Range
$19.58 - $42.21
Target Price
--
NAMS earnings and financial statements: NewAmsterdam Pharma Company N.V.'s income statement, balance sheet and cash flow statement, annual and quarterly.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $19.71 | -8.7% | 2.31M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW